-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTINIUM PHARMACEUTICALS PRESENTS EANM 2026 RESULTS REINFORCING ATNM-400'S PAN-TUMOR POTENTIAL ACROSS LUNG, COLORECTAL AND OVARIAN CANCER MODELS

Reuters·10/20/2026 11:30:02

Please log in to view news